Fig. 2From: Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trialPrimary cognitive outcomes in dabigatran and warfarin groups. There were no significant differences between dabigatran and warfarin treatment groups for most of the cognitive tests at 2Â years (except for MoCA) in comparison to baseline. Comparison between D and W groups for the four tests that represent the primary cognitive outcomes. Differences between groups (95% CI) are expressed in the adjusted mean change from baseline (points) and 95% confidence intervals (segments) for the four primary outcomesBack to article page